A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced Osteosarcoma

Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

The purpose was to evaluate efficacy, safety and effects on survival for lobaplatin and Gemcitabine in combination with Docetaxel, which can provide a kind of completely new second-line chemotherapy program for osteosarcoma patients in aggressive-phase, provide accurate and reliable evidence-based results for clinical applications of lobaplatin in osteosarcoma patients as one of the third-generation of platinum drugs, and further consummate and enrich clinical practice guidance on osteosarcoma all over the world.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma
• Osteosarcoma

• NCT number: NCT02099396
• Study type: Interventional
• Source: China Association of Osteosarcoma Chemotherapy
• Status: Not yet recruiting
• Phase: Phase 2/Phase 3
• Start date: April 2014